386 related articles for article (PubMed ID: 7545554)
1. Increased central nervous system monoamine neurotransmitter turnover and its association with sympathetic nervous activity in treated heart failure patients.
Lambert GW; Kaye DM; Lefkovits J; Jennings GL; Turner AG; Cox HS; Esler MD
Circulation; 1995 Oct; 92(7):1813-8. PubMed ID: 7545554
[TBL] [Abstract][Full Text] [Related]
2. Neurochemical evidence of cardiac sympathetic activation and increased central nervous system norepinephrine turnover in severe congestive heart failure.
Kaye DM; Lambert GW; Lefkovits J; Morris M; Jennings G; Esler MD
J Am Coll Cardiol; 1994 Mar; 23(3):570-8. PubMed ID: 8113536
[TBL] [Abstract][Full Text] [Related]
3. Central nervous system monoamine neurotransmitter turnover in primary and obesity-related human hypertension.
Esler M; Lambert G; Vaz M; Thompson J; Kaye D; Kalff V; Kelly M; Turner A; Jennings G
Clin Exp Hypertens; 1997; 19(5-6):577-90. PubMed ID: 9247740
[TBL] [Abstract][Full Text] [Related]
4. Internal jugular venous spillover of noradrenaline and metabolites and their association with sympathetic nervous activity.
Lambert GW; Kaye DM; Thompson JM; Turner AG; Cox HS; Vaz M; Jennings GL; Wallin BG; Esler MD
Acta Physiol Scand; 1998 Jun; 163(2):155-63. PubMed ID: 9648634
[TBL] [Abstract][Full Text] [Related]
5. Norepinephrine turnover is increased in suprabulbar subcortical brain regions and is related to whole-body sympathetic activity in human heart failure.
Aggarwal A; Esler MD; Lambert GW; Hastings J; Johnston L; Kaye DM
Circulation; 2002 Mar; 105(9):1031-3. PubMed ID: 11877349
[TBL] [Abstract][Full Text] [Related]
6. Cardiac sympathetic nervous activity in congestive heart failure. Evidence for increased neuronal norepinephrine release and preserved neuronal uptake.
Meredith IT; Eisenhofer G; Lambert GW; Dewar EM; Jennings GL; Esler MD
Circulation; 1993 Jul; 88(1):136-45. PubMed ID: 8391399
[TBL] [Abstract][Full Text] [Related]
7. Effect of cardiac sympathetic nervous activity on mode of death in congestive heart failure.
Brunner-La Rocca HP; Esler MD; Jennings GL; Kaye DM
Eur Heart J; 2001 Jul; 22(13):1136-43. PubMed ID: 11428854
[TBL] [Abstract][Full Text] [Related]
8. Digoxin reduces cardiac sympathetic activity in severe congestive heart failure.
Newton GE; Tong JH; Schofield AM; Baines AD; Floras JS; Parker JD
J Am Coll Cardiol; 1996 Jul; 28(1):155-61. PubMed ID: 8752808
[TBL] [Abstract][Full Text] [Related]
9. Measurement of sympathetic nervous system activity in heart failure: the role of norepinephrine kinetics.
Esler M; Kaye D
Heart Fail Rev; 2000 Mar; 5(1):17-25. PubMed ID: 16228913
[TBL] [Abstract][Full Text] [Related]
10. Effects of aging on the responsiveness of the human cardiac sympathetic nerves to stressors.
Esler MD; Thompson JM; Kaye DM; Turner AG; Jennings GL; Cox HS; Lambert GW; Seals DR
Circulation; 1995 Jan; 91(2):351-8. PubMed ID: 7805237
[TBL] [Abstract][Full Text] [Related]
11. Increased sympathetic nervous system activity and its therapeutic reduction in arterial hypertension, portal hypertension and heart failure.
Esler M; Kaye D
J Auton Nerv Syst; 1998 Oct; 72(2-3):210-9. PubMed ID: 9851571
[TBL] [Abstract][Full Text] [Related]
12. The influence of aging on the human sympathetic nervous system and brain norepinephrine turnover.
Esler M; Hastings J; Lambert G; Kaye D; Jennings G; Seals DR
Am J Physiol Regul Integr Comp Physiol; 2002 Mar; 282(3):R909-16. PubMed ID: 11832414
[TBL] [Abstract][Full Text] [Related]
13. Cardiac autonomic function in Blacks with congestive heart failure: vagomimetic action, alteration in sympathovagal balance, and the effect of ACE inhibition on central and peripheral vagal tone.
Adigun AQ; Asiyanbola B; Ajayi AA
Cell Mol Biol (Noisy-le-grand); 2001 Sep; 47(6):1063-7. PubMed ID: 11785658
[TBL] [Abstract][Full Text] [Related]
14. Cardiac sympathetic dysautonomia in chronic orthostatic intolerance syndromes.
Goldstein DS; Holmes C; Frank SM; Dendi R; Cannon RO; Sharabi Y; Esler MD; Eisenhofer G
Circulation; 2002 Oct; 106(18):2358-65. PubMed ID: 12403667
[TBL] [Abstract][Full Text] [Related]
15. Jugular venous overflow of noradrenaline from the brain: a neurochemical indicator of cerebrovascular sympathetic nerve activity in humans.
Mitchell DA; Lambert G; Secher NH; Raven PB; van Lieshout J; Esler MD
J Physiol; 2009 Jun; 587(Pt 11):2589-97. PubMed ID: 19403604
[TBL] [Abstract][Full Text] [Related]
16. Adverse consequences of high sympathetic nervous activity in the failing human heart.
Kaye DM; Lefkovits J; Jennings GL; Bergin P; Broughton A; Esler MD
J Am Coll Cardiol; 1995 Nov; 26(5):1257-63. PubMed ID: 7594040
[TBL] [Abstract][Full Text] [Related]
17. Regional origins of 3-methoxy-4-hydroxyphenylglycol in plasma: effects of chronic sympathetic nervous activation and denervation, and acute reflex sympathetic stimulation.
Lambert GW; Kaye DM; Vaz M; Cox HS; Turner AG; Jennings GL; Esler MD
J Auton Nerv Syst; 1995 Nov; 55(3):169-78. PubMed ID: 8801267
[TBL] [Abstract][Full Text] [Related]
18. Cardiac sympathetic nerve biology and brain monoamine turnover in panic disorder.
Esler M; Alvarenga M; Lambert G; Kaye D; Hastings J; Jennings G; Morris M; Schwarz R; Richards J
Ann N Y Acad Sci; 2004 Jun; 1018():505-14. PubMed ID: 15240408
[TBL] [Abstract][Full Text] [Related]
19. Acute effects of beta 1-selective and nonselective beta-adrenergic receptor blockade on cardiac sympathetic activity in congestive heart failure.
Newton GE; Parker JD
Circulation; 1996 Aug; 94(3):353-8. PubMed ID: 8759076
[TBL] [Abstract][Full Text] [Related]
20. Sympathetic nervous function in human heart as assessed by cardiac spillovers of dihydroxyphenylglycol and norepinephrine.
Eisenhofer G; Esler MD; Meredith IT; Dart A; Cannon RO; Quyyumi AA; Lambert G; Chin J; Jennings GL; Goldstein DS
Circulation; 1992 May; 85(5):1775-85. PubMed ID: 1572033
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
